You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 諾泰生物連續2日大升 上半年淨利預增超330%
格隆匯 06-21 10:15

減肥藥概念股持續活躍,其中諾泰生物(688076.SH)再度拉昇升超8%,2日連升近30%,股價重回80元上方且創3年新高價,總市值168億元。消息面上,公司預測2024年半年度將實現歸屬於母公司所有者的淨利潤為1.8億元至2.5億元,相比去年同期大幅增長330.08%至497.34%。這一業績的提升主要歸功於公司自主選擇產品的持續放量以及收入佔比的顯著提升。業內預計,到2028年,全球減肥藥市場規模將達到284億美元。諾泰生物等醫藥企業切中市場痛點,以前瞻性的眼光和創新性的解決方案,搶佔了減肥藥風口的有利位置。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account